Annie Yoshiyama
Senior VP of Finance, Corporate Controller & Principal Accounting OfficerMs. Annie Yoshiyama was Senior Vice President and Corporate Controller at Allogene Therapeutics, Inc. since June 5, 2024 until September 2026 and serves as its Senior VP of Finance, Corporate Controller & Principal Accounting Officer since September 2026. She served as Vice President, Finance and Corporate Controller at AN2 Therapeutics, Inc. from September 15, 2023 to March 2024. She served as Vice President of Finance and Chief Accounting Officer at Tricida, Inc. since December 4, 2020. From June 2018 to March 2023, she served at Tricida, Inc in various positions as Senior Vice President Finance, Executive Director of Finance, Senior Director of Finance, Director of SEC Reporting and Technical Accounting and Associate Director of SEC Reporting and Technical Accounting. Ms. Yoshiyama has experience in corporate accounting, including financial planning and analysis, financial reporting, technical accounting and stock administration. Previously, Ms. Yoshiyama served as Executive Director, Finance for the Company. Prior to joining the Company, Ms. Yoshiyama served as Senior Financial Reporting and Technical Accounting Manager at Dolby Laboratories from September 2008 to June 2018 where she coordinated the quarterly financial reporting process. She started her career in audit at PricewaterhouseCoopers LLP from 2005 to 2008 in the firm's real estate and technology practices. Ms. Yoshiyama holds a Bachelors of Science and a Masters in Accounting from the University of Southern California and is a licensed Certified Public Accountant.
Positions
- Company NameAllogene Therapeutics, Inc.Stock CodeALLOPositionSenior VP of Finance, Corporate Controller & Principal Accounting Officer
